These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 16815012)

  • 1. Tetrahydrofluorenones with conformationally restricted side chains as selective estrogen receptor beta ligands.
    Wildonger KJ; Ratcliffe RW; Mosley RT; Hammond ML; Birzin ET; Rohrer SP
    Bioorg Med Chem Lett; 2006 Sep; 16(17):4462-6. PubMed ID: 16815012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triazolo-tetrahydrofluorenones as selective estrogen receptor beta agonists.
    Parker DL; Meng D; Ratcliffe RW; Wilkening RR; Sperbeck DM; Greenlee ML; Colwell LF; Lambert S; Birzin ET; Frisch K; Rohrer SP; Nilsson S; Thorsell AG; Hammond ML
    Bioorg Med Chem Lett; 2006 Sep; 16(17):4652-6. PubMed ID: 16777408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The discovery of tetrahydrofluorenones as a new class of estrogen receptor beta-subtype selective ligands.
    Wilkening RR; Ratcliffe RW; Tynebor EC; Wildonger KJ; Fried AK; Hammond ML; Mosley RT; Fitzgerald PM; Sharma N; McKeever BM; Nilsson S; Carlquist M; Thorsell A; Locco L; Katz R; Frisch K; Birzin ET; Wilkinson HA; Mitra S; Cai S; Hayes EC; Schaeffer JM; Rohrer SP
    Bioorg Med Chem Lett; 2006 Jul; 16(13):3489-94. PubMed ID: 16632357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen receptor beta-subtype selective tetrahydrofluorenones: use of a fused pyrazole as a phenol bioisostere.
    Wilkening RR; Ratcliffe RW; Fried AK; Meng D; Sun W; Colwell L; Lambert S; Greenlee M; Nilsson S; Thorsell A; Mojena M; Tudela C; Frisch K; Chan W; Birzin ET; Rohrer SP; Hammond ML
    Bioorg Med Chem Lett; 2006 Aug; 16(15):3896-901. PubMed ID: 16730987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Descriptor analysis of estrogen receptor β-selective ligands using 2-phenylquinoline, tetrahydrofluorenone and 3-hydroxy 6H-benzo[c]chromen-6-one scaffolds.
    Balaji ; Muthiah R; Sabarinath ; Ramamurthy ; Chandrasekharan
    J Enzyme Inhib Med Chem; 2011 Dec; 26(6):831-42. PubMed ID: 21438712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A structure-guided approach to an orthogonal estrogen-receptor-based gene switch activated by ligands suitable for in vivo studies.
    Kinzel O; Fattori D; Muraglia E; Gallinari P; Nardi MC; Paolini C; Roscilli G; Toniatti C; Gonzalez Paz O; Laufer R; Lahm A; Tramontano A; Cortese R; De Francesco R; Ciliberto G; Koch U
    J Med Chem; 2006 Sep; 49(18):5404-7. PubMed ID: 16942012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of anthranylaldoxime derivatives as estrogen receptor ligands and computational prediction of binding modes.
    Tuccinardi T; Bertini S; Martinelli A; Minutolo F; Ortore G; Placanica G; Prota G; Rapposelli S; Carlson KE; Katzenellenbogen JA; Macchia M
    J Med Chem; 2006 Aug; 49(16):5001-12. PubMed ID: 16884312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ERbeta ligands. Part 6: 6H-Chromeno[4,3-b]quinolines as a new series of estrogen receptor beta-selective ligands.
    Vu AT; Campbell AN; Harris HA; Unwalla RJ; Manas ES; Mewshaw RE
    Bioorg Med Chem Lett; 2007 Jul; 17(14):4053-6. PubMed ID: 17482813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computational insights into the mechanism of ligand unbinding and selectivity of estrogen receptors.
    Shen J; Li W; Liu G; Tang Y; Jiang H
    J Phys Chem B; 2009 Jul; 113(30):10436-44. PubMed ID: 19583238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insights into ligand selectivity in estrogen receptor isoforms: molecular dynamics simulations and binding free energy calculations.
    Zeng J; Li W; Zhao Y; Liu G; Tang Y; Jiang H
    J Phys Chem B; 2008 Mar; 112(9):2719-26. PubMed ID: 18266357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New scaffolds for the design of selective estrogen receptor modulators.
    Martín-Santamaría S; Rodríguez JJ; de Pascual-Teresa S; Gordon S; Bengtsson M; Garrido-Laguna I; Rubio-Viqueira B; López-Casas PP; Hidalgo M; de Pascual-Teresa B; Ramos A
    Org Biomol Chem; 2008 Oct; 6(19):3486-96. PubMed ID: 19082149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bridged androstenediol analogs as ER-beta selective SERMs.
    Blizzard TA; Gude C; Chan W; Birzin ET; Mojena M; Tudela C; Chen F; Knecht K; Su Q; Kraker B; Holmes MA; Rohrer SP; Hammond ML
    Bioorg Med Chem Lett; 2007 May; 17(10):2944-8. PubMed ID: 17448656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ERbeta ligands. Part 4: Synthesis and structure-activity relationships of a series of 2-phenylquinoline derivatives.
    Vu AT; Cohn ST; Manas ES; Harris HA; Mewshaw RE
    Bioorg Med Chem Lett; 2005 Oct; 15(20):4520-5. PubMed ID: 16098741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen receptor beta selective ligands: discovery and SAR of novel heterocyclic ligands.
    Chesworth R; Wessel MD; Heyden L; Mangano FM; Zawistoski M; Gegnas L; Galluzzo D; Lefker B; Cameron KO; Tickner J; Lu B; Castleberry TA; Petersen DN; Brault A; Perry P; Ng O; Owen TA; Pan L; Ke HZ; Brown TA; Thompson DD; DaSilva-Jardine P
    Bioorg Med Chem Lett; 2005 Dec; 15(24):5562-6. PubMed ID: 16219463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 7-Substituted 2-phenyl-benzofurans as ER beta selective ligands.
    Collini MD; Kaufman DH; Manas ES; Harris HA; Henderson RA; Xu ZB; Unwalla RJ; Miller CP
    Bioorg Med Chem Lett; 2004 Oct; 14(19):4925-9. PubMed ID: 15341953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of 3-alkyl naphthalenes as novel estrogen receptor ligands.
    Fang J; Akwabi-Ameyaw A; Britton JE; Katamreddy SR; Navas F; Miller AB; Williams SP; Gray DW; Orband-Miller LA; Shearin J; Heyer D
    Bioorg Med Chem Lett; 2008 Sep; 18(18):5075-7. PubMed ID: 18722117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoaryl-substituted salicylaldoximes as ligands for estrogen receptor beta.
    Minutolo F; Bellini R; Bertini S; Carboni I; Lapucci A; Pistolesi L; Prota G; Rapposelli S; Solati F; Tuccinardi T; Martinelli A; Stossi F; Carlson KE; Katzenellenbogen BS; Katzenellenbogen JA; Macchia M
    J Med Chem; 2008 Mar; 51(5):1344-51. PubMed ID: 18269232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural evolutions of salicylaldoximes as selective agonists for estrogen receptor beta.
    Minutolo F; Bertini S; Granchi C; Marchitiello T; Prota G; Rapposelli S; Tuccinardi T; Martinelli A; Gunther JR; Carlson KE; Katzenellenbogen JA; Macchia M
    J Med Chem; 2009 Feb; 52(3):858-67. PubMed ID: 19128016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benzopyrans are selective estrogen receptor beta agonists with novel activity in models of benign prostatic hyperplasia.
    Norman BH; Dodge JA; Richardson TI; Borromeo PS; Lugar CW; Jones SA; Chen K; Wang Y; Durst GL; Barr RJ; Montrose-Rafizadeh C; Osborne HE; Amos RM; Guo S; Boodhoo A; Krishnan V
    J Med Chem; 2006 Oct; 49(21):6155-7. PubMed ID: 17034120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and evaluation of hexahydrochrysene and tetrahydrobenzofluorene ligands for the estrogen receptor.
    Tedesco R; Youngman MK; Wilson SR; Katzenellenbogen JA
    Bioorg Med Chem Lett; 2001 May; 11(10):1281-4. PubMed ID: 11392537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.